Parexel launches new community alliance network EP News Bureau Jun 17, 2022 The initiative seeks to expand patient access to clinical trials
Oral COVID vaccine protects against disease, transmission: Study Press Trust of India May 9, 2022 The research, published in the journal "Science Translational Medicine," demonstrates the potential of the vaccine to work through…
HIV drugs may curb COVID-19 risk Reuters Mar 29, 2022 Some new treatments for COVID-19 use protease inhibitors, which block the virus from multiplying
Bayer submits application in EU for extension of finerenone to include early stages of CKD… EP News Bureau Mar 17, 2022 Regulatory submission is based on positive data from the pivotal phase-III FIGARO-DKD study, published in the 'New England Journal…
COVID vaccine doesn’t raise risk of rare inflammation in children: Lancet IANS Feb 24, 2022 The reporting rate of MIS-C for those without evidence of SARS-CoV-2 infection was 0.3 cases per million vaccinated individuals
Enhertu improves both progression-free and overall survival in Destiny-Breast04 trial in patients… EP News Bureau Feb 22, 2022 First HER2-low metastatic breast cancer phase-III results for AstraZeneca and Daiichi Sankyo’s Enhertu offer potential to redefine…
COVID vaccines induce robust protection against severe disease from Omicron Press Trust of India Feb 3, 2022 The research demonstrated that the vaccines induce this protection through cellular immunity or the production of protective…
FDA approves Roche’s Vabysmo to treat nAMD and DME EP News Bureau Feb 1, 2022 Vabysmo is the only injectable eye medicine approved simultaneously in the US for neovascular Age-related Macular Degeneration…
Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet EP News Bureau Jan 26, 2022 All four studies met their primary endpoints, showing that people treated with Faricimab up to every four months achieved…
Scientists develop molecule that blocks COVID-19 infection Press Trust of India Dec 16, 2021 The researchers at Aarhus University in Denmark noted that the molecule is cheaper and easier to manufacture than the antibodies…